DiMartino Jorge 4
4 · Kronos Bio, Inc. · Filed Dec 14, 2022
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
DiMartino Jorge
Chief Medical Officer & VP
Transactions
- Sale
Common Stock
2022-12-12$1.81/sh−18,657$33,680→ 219,478 total
Footnotes (1)
- [F1]Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.